Prognostic value of androgen receptor in triple negative breast cancer: A meta-analysis

BACKGROUND: Androgen receptor (AR) is a promising therapeutic target for breast cancer. However, its prognostic value remains controversial in triple negative breast cancer (TNBC). Here we present a meta-analysis to investigate the correlation between AR expression and TNBC prognosis. RESULTS: Thirt...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Changjun, Pan, Bo, Zhu, Hanjiang, Zhou, Yidong, Mao, Feng, Lin, Yan, Xu, Qianqian, Sun, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216811/
https://www.ncbi.nlm.nih.gov/pubmed/27374089
http://dx.doi.org/10.18632/oncotarget.10208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216811/
https://www.ncbi.nlm.nih.gov/pubmed/27374089
http://dx.doi.org/10.18632/oncotarget.10208

Ejemplares similares